Efficacy of fluid assessment based on intrathoracic impedance monitoring in patients with systolic heart failure

Circulation Journal

Volumn 75, Issue 1, 2011, Pages 129-134

  Soga, Yoshimitsu ^a   Ando, Kenji ^a   Arita, Takeshi ^a   Hyodo, Makoto ^a   Goya, Masahiko ^a   Iwabuchi, Masashi ^a   Nobuyoshi, Masakiyo ^a  

^a KOKURA MEMORIAL HOSPITAL   (Japan)

Author keywords

Cardiac device; Heart failure; Intrathoracic impedance

Indexed keywords

AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR SYSTEM EXAMINATION; CLINICAL EFFECTIVENESS; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATION; FALSE POSITIVE RESULT; FEMALE; FLUID BALANCE; FOLLOW UP; GENERAL CONDITION DETERIORATION; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE OVERLOAD; HOSPITAL PATIENT; HUMAN; INTRATHORACIC IMPEDANCE MONITORING; JAPANESE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PREDICTIVE VALUE; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SYSTOLIC HEART FAILURE;

AGED; ATRIAL FIBRILLATION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICES; CARDIOGRAPHY, IMPEDANCE; CHI-SQUARE DISTRIBUTION; CLINICAL ALARMS; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC IMPEDANCE; EQUIPMENT DESIGN; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; WATER-ELECTROLYTE IMBALANCE;

EID: 78651225687     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-10-0730     Document Type: Article

References (18)

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2010 update: A report from the American Heart Association. Circulation 2010; 121: e46-e215.
2. Miyagishima K, Hiramitsu S, Kimura H, Mori K, Ueda T, Kato S, et al. Long term prognosis of chronic heart failure: Reduced vs preserved left ventricular ejection fraction. Circ J 2009; 73: 92-99.
3. Iwanaga Y, Miyazaki S. Heart failure, chronic kidney disease, and biomarkers: An integrated viewpoint. Circ J 2010; 74: 1274-1282.
4. Sata Y, Krum H. The future of pharmacological therapy for heart failure. Circ J 2010; 74: 809-817.
5. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, et al; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Euro-Heart Failure survey programme--a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003; 24: 442-463.
6. McMurray JJ, Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000; 83: 596-602.
7. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442.
8. Yu CM, Wang L, Chau E, Chan RH, Kong SL, Tang MO, et al. Intrathoracic impedance monitoring in patients with heart failure: Correlation with fuid status and feasibility of early warning preceding hospitalization. Circulation 2005; 112: 841-848.
9. Vollmann D, Nägele H, Schauerte P, Wiegand U, Butter C, Zanotto G, et al; European InSync Sentry Observational Study Investigators. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J 2007; 28: 1835-1840.
10. Lüthje L, Drescher T, Zenker D, Vollmann D. Detection of heart failure decompensation using intrathoracic impedance monitoring by a triple-chamber implantable defbrillator. Heart Rhythm 2005; 2: 997-999.
11. Lüthje L, Vollmann D, Drescher T, Schott P, Zenker D, Hasenfuss G, et al. Intrathoracic impedance monitoring to detect chronic heart failure deterioration: Relationship to changes in NT-proBNP. Eur J Heart Fail 2007; 9: 716-722.
12. Catanzariti D, Lunati M, Landolina M, Zanotto G, Lonardi G, Iacopino S, et al; Italian Clinical Service Optivol-CRT Group. Monitoring intrathoracic impedance with an implantable defbrillator reduces hospitalizations in patients with heart failure. Pacing Clin Electrophysiol 2009; 32: 363-370.
13. Ypenburg C, Bax JJ, van der Wall EE, Schalij MJ, van Erven L. Intrathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol 2007; 99: 554-557.
14. Friedman MM. Older adults' symptoms and their duration before hospitalization for heart failure. Heart Lung 1997; 26: 169-176.
15. Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, et al; PARTNERS Study Investigators. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: Results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol 2010; 55: 1803-1810.
16. Small RS, Wickemeyer W, Germany R, Hoppe B, Andrulli J, Brady PA, et al. Changes in intrathoracic impedance are associated with subsequent risk of hospitalizations for acute decompensated heart failure: Clinical utility of implanted device monitoring without a patient alert. J Card Fail 2009; 15: 475-481.
17. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fbrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med 2002; 113: 359-364.
18. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fbrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-844.